annual retained earnings:
-$2.20B+$226.45M(+9.32%)Summary
- As of today (May 18, 2025), ACAD annual retained earnings is -$2.20 billion, with the most recent change of +$226.45 million (+9.32%) on December 31, 2024.
- During the last 3 years, ACAD annual retained earnings has fallen by -$50.81 million (-2.36%).
- ACAD annual retained earnings is now -3961.64% below its all-time high of -$54.27 million, reached on December 31, 2002.
Performance
ACAD Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
-$2.19B+$18.99M(+0.86%)Summary
- As of today (May 18, 2025), ACAD quarterly retained earnings is -$2.19 billion, with the most recent change of +$18.99 million (+0.86%) on March 31, 2025.
- Over the past year, ACAD quarterly retained earnings has increased by +$228.88 million (+9.48%).
- ACAD quarterly retained earnings is now -3096.62% below its all-time high of -$68.37 million, reached on December 31, 2003.
Performance
ACAD quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ACAD Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.3% | +9.5% |
| 3 y3 years | -2.4% | +3.6% |
| 5 y5 years | -29.4% | -21.9% |
ACAD Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.4% | +9.3% | at high | +11.8% |
| 5 y | 5-year | -29.4% | +9.3% | -21.9% | +11.8% |
| alltime | all time | -3961.6% | +9.3% | -3096.6% | +11.8% |
ACAD Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -$2.19B(-0.9%) |
| Dec 2024 | -$2.20B(-9.3%) | -$2.20B(-6.1%) |
| Sep 2024 | - | -$2.35B(-1.4%) |
| Jun 2024 | - | -$2.38B(-1.4%) |
| Mar 2024 | - | -$2.41B(-0.7%) |
| Dec 2023 | -$2.43B(+2.6%) | -$2.43B(-1.8%) |
| Sep 2023 | - | -$2.48B(+2.7%) |
| Jun 2023 | - | -$2.41B(-0.0%) |
| Mar 2023 | - | -$2.41B(+1.8%) |
| Dec 2022 | -$2.37B(+10.0%) | -$2.37B(+1.8%) |
| Sep 2022 | - | -$2.33B(+1.2%) |
| Jun 2022 | - | -$2.30B(+1.5%) |
| Mar 2022 | - | -$2.27B(+5.2%) |
| Dec 2021 | -$2.15B(+8.5%) | -$2.15B(+2.0%) |
| Sep 2021 | - | -$2.11B(+0.7%) |
| Jun 2021 | - | -$2.10B(+2.1%) |
| Mar 2021 | - | -$2.05B(+3.3%) |
| Dec 2020 | -$1.99B(+16.5%) | -$1.99B(+3.5%) |
| Sep 2020 | - | -$1.92B(+4.6%) |
| Jun 2020 | - | -$1.83B(+2.4%) |
| Mar 2020 | - | -$1.79B(+5.2%) |
| Dec 2019 | -$1.70B(+16.0%) | -$1.70B(+3.2%) |
| Sep 2019 | - | -$1.65B(+2.6%) |
| Jun 2019 | - | -$1.61B(+3.5%) |
| Mar 2019 | - | -$1.55B(+5.8%) |
| Dec 2018 | -$1.47B(+20.0%) | -$1.47B(+4.7%) |
| Sep 2018 | - | -$1.40B(+4.6%) |
| Jun 2018 | - | -$1.34B(+5.0%) |
| Mar 2018 | - | -$1.28B(+4.4%) |
| Dec 2017 | -$1.22B(+31.0%) | -$1.22B(+6.0%) |
| Sep 2017 | - | -$1.15B(+6.0%) |
| Jun 2017 | - | -$1.09B(+6.6%) |
| Mar 2017 | - | -$1.02B(+9.4%) |
| Dec 2016 | -$933.98M(+41.0%) | -$933.98M(+9.2%) |
| Sep 2016 | - | -$855.28M(+9.1%) |
| Jun 2016 | - | -$783.67M(+10.0%) |
| Mar 2016 | - | -$712.35M(+7.5%) |
| Dec 2015 | -$662.59M(+33.0%) | -$662.59M(+7.4%) |
| Sep 2015 | - | -$616.80M(+6.7%) |
| Jun 2015 | - | -$577.90M(+7.3%) |
| Mar 2015 | - | -$538.52M(+8.1%) |
| Dec 2014 | -$498.14M | -$498.14M(+6.0%) |
| Sep 2014 | - | -$469.78M(+5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | -$444.99M(+5.1%) |
| Mar 2014 | - | -$423.50M(+4.4%) |
| Dec 2013 | -$405.67M(+10.3%) | -$405.67M(+3.1%) |
| Sep 2013 | - | -$393.62M(+2.8%) |
| Jun 2013 | - | -$382.92M(+2.4%) |
| Mar 2013 | - | -$373.84M(+1.7%) |
| Dec 2012 | -$367.72M(+6.0%) | -$367.72M(+1.9%) |
| Sep 2012 | - | -$360.91M(+0.7%) |
| Jun 2012 | - | -$358.51M(+1.5%) |
| Mar 2012 | - | -$353.09M(+1.8%) |
| Dec 2011 | -$346.87M(+7.0%) | -$346.87M(+1.6%) |
| Sep 2011 | - | -$341.57M(+1.5%) |
| Jun 2011 | - | -$336.50M(+2.0%) |
| Mar 2011 | - | -$329.94M(+1.8%) |
| Dec 2010 | -$324.11M(-4.5%) | -$324.11M(-8.2%) |
| Sep 2010 | - | -$353.25M(+1.2%) |
| Jun 2010 | - | -$349.02M(+1.2%) |
| Mar 2010 | - | -$344.73M(+1.6%) |
| Dec 2009 | -$339.25M(+15.4%) | -$339.25M(+2.6%) |
| Sep 2009 | - | -$330.56M(+2.7%) |
| Jun 2009 | - | -$321.83M(+4.1%) |
| Mar 2009 | - | -$309.10M(+5.1%) |
| Dec 2008 | -$294.10M(+27.9%) | -$294.10M(+5.0%) |
| Sep 2008 | - | -$280.14M(+5.9%) |
| Jun 2008 | - | -$264.52M(+7.4%) |
| Mar 2008 | - | -$246.24M(+7.1%) |
| Dec 2007 | -$229.86M(+32.5%) | -$229.86M(+8.0%) |
| Sep 2007 | - | -$212.82M(+8.2%) |
| Jun 2007 | - | -$196.77M(+5.8%) |
| Mar 2007 | - | -$186.02M(+7.2%) |
| Dec 2006 | -$173.47M(+35.1%) | -$173.47M(+7.7%) |
| Sep 2006 | - | -$161.02M(+7.5%) |
| Jun 2006 | - | -$149.75M(+8.6%) |
| Mar 2006 | - | -$137.88M(+7.4%) |
| Dec 2005 | -$128.42M(+36.2%) | -$128.42M(+8.6%) |
| Sep 2005 | - | -$118.22M(+11.6%) |
| Jun 2005 | - | -$105.91M(+6.0%) |
| Mar 2005 | - | -$99.87M(+5.9%) |
| Dec 2004 | -$94.28M(+37.9%) | -$94.28M(+8.4%) |
| Sep 2004 | - | -$86.95M(+7.7%) |
| Jun 2004 | - | -$80.73M(+7.9%) |
| Mar 2004 | - | -$74.85M(+9.5%) |
| Dec 2003 | -$68.37M(+26.0%) | -$68.37M |
| Dec 2002 | -$54.27M | - |
FAQ
- What is ACADIA Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual retained earnings year-on-year change?
- What is ACADIA Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly retained earnings year-on-year change?
What is ACADIA Pharmaceuticals annual retained earnings?
The current annual retained earnings of ACAD is -$2.20B
What is the all time high annual retained earnings for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual retained earnings is -$54.27M
What is ACADIA Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ACAD annual retained earnings has changed by +$226.45M (+9.32%)
What is ACADIA Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ACAD is -$2.19B
What is the all time high quarterly retained earnings for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly retained earnings is -$68.37M
What is ACADIA Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ACAD quarterly retained earnings has changed by +$228.88M (+9.48%)